by brainteaser | Dec 16, 2021 | News
As part of its dissemination core set of activities, BRAINTEASER reached out to other EU funded Horizon2020 projects with similar objectives and common challenges with the aim to identify potential areas of collaboration. A first meeting took place in October 2021...
by brainteaser | Dec 16, 2021 | News
One of the main objectives of the BRAINTEASER project is to exploit its results with the ultimate aim of improving care and quality of life of ALS and MS patients. To accompany the BRAINTEASER Consortium towards the most suitable results’ sustainability and...
by brainteaser | Dec 16, 2021 | News
The BRAINTEASER community of practice will focus on the clinical use of Artificial Intelligence and digital tools to manage ALS and MS disease. It will be an innovation community to create new breakthrough ideas, approaches, and knowledge. The community will target...
by brainteaser | Dec 16, 2021 | News
On November 16th, the 17th Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021) hosted the Special Session “Artificial Intelligence and Statistical Methods for Neurodegenerative Diseases”. The special session was organized...
by brainteaser | Dec 16, 2021 | News
The Intelligent Disease Progression Prediction (iDPP) challenge aims at designing and developing an evaluation infrastructure for AI algorithms able to: ● better describe disease mechanisms; ● stratify patients...
